feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / FDA to Test Dairy Ingredients for Infant Botulism Spores

FDA to Test Dairy Ingredients for Infant Botulism Spores

4 Feb

•

Summary

  • US officials will test dairy ingredients for infant botulism spores.
  • Testing follows last year's ByHeart recall linked to infant hospitalizations.
  • New testing aims to assess supply chain risks and future company requirements.
FDA to Test Dairy Ingredients for Infant Botulism Spores

US health officials are set to test certain dairy-based ingredients, including milk powder and whey protein concentrate, for spores that can lead to infant botulism. This proactive measure comes after a recall by ByHeart last year, which was associated with 51 infant hospitalizations.

The Food and Drug Administration's initiative seeks to understand potential contamination risks within the supply chain. Officials are evaluating whether the presence of these spores constitutes a foreseeable hazard that manufacturers should actively test for.

Currently, there is no indication that the U.S. infant formula supply is unsafe. However, this ingredient testing is a crucial step to assess the overall supply chain and inform future regulatory actions. The agency is considering mandating spore testing for infant formula makers, a possibility that has not been a requirement previously.

trending

Tanker stalls Mumbai-Pune expressway

trending

Gemini imports ChatGPT chats

trending

Women's FA Cup changes

trending

ChatGPT outage reported today

trending

Sundar fitness doubt for World

trending

Lakers beat Nets, 112-100

trending

India vs South Africa warm-up

trending

2026 Winter Olympics details

trending

HDFC Bank share price target

ByHeart has temporarily halted production and is awaiting the FDA's investigation results before resuming operations. The timeline for ByHeart's return to production remains uncertain as the FDA continues its inspections and analysis.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The FDA plans to test dairy-based ingredients such as milk powder and whey protein concentrate for spores that can cause infant botulism.
This testing is a response to a previous recall linked to infant hospitalizations and aims to evaluate the supply chain for potential contamination risks.
It is a real possibility that infant formula companies may be required in the future to test for Clostridium botulinum spores.

Read more news on

Healthside-arrow

You may also like

Botulism Bacteria Found in Infant Formula Samples

26 Jan • 68 reads

article image

ByHeart Formula: Years of Contamination Feared

11 Dec, 2025 • 333 reads

article image

Botulism Spreads: All ByHeart Formula Linked to Sickness

11 Dec, 2025 • 364 reads

article image

Deadly Botulism Threatens Babies: Formula Still on Shelves

5 Dec, 2025 • 352 reads

article image

New Glasses Slow Kids' Nearsightedness

1 Dec, 2025 • 354 reads